ARCHIVES

In Brief: FDA Cool To Committee Review of INDs; New Commissioner Is Donald Kennedy, Of Stanford

This article is from The Cancer Letter archive.

Vol. 03 No. 10 | March 11, 1977

Download PDF Visit The Full Archive

Related Articles

NCI funds nine centers for $14.9 million integrative biology program.

October 29, 2004

FDA Advisors OK Levamisole, Conditional New Tamoxifen Use

February 9, 1990

Study Shows Early Treatment Of Asymptomatic Myeloma Can Improve Survival

August 30, 2013

Hematologic Malignancies: ASCO Meeting Highlights New Approaches To Treatment

July 30, 2004

Patient Advocacy: Policy Should Prevent Employers From Using Genetic Test Results

April 11, 1997

In Congress; GAO Says Some Yew Bark Lost In ’91, But Problems Are Being Corrected

September 11, 1992